Establishing secure connection…Loading editor…Preparing document…

Healthcare Pharmacovigilance Activities Form

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

Healthcare Pharmacovigilance Activities Form

Report Header

Report Type:   Report Date:

Patient Information

Date of Birth:   Gender:

Phone:   Email:

Reporter Details

Institution / Facility:   Contact Phone:

Suspected Product(s)

Manufacturer:   Lot/Batch Number:

Dose / Strength:   Route of Administration:   Start Date:

Adverse Event Details

Onset Date of First Symptom:   Resolution Date (if applicable):

Hospitalization or prolonged hospitalization    Life-threatening condition    Persistent or significant disability/incapacity

Congenital anomaly/birth defect    Death    Other (specify below)

Concomitant Products and Medical History

Outcome, Assessment and Actions

Event Outcome:   Reporter Assessment of Causality:

Confidentiality, Authorization and Legal Statements

By submitting this report I certify that the information provided is true and accurate to the best of my knowledge. I authorize collection, use and disclosure of identifiable and de-identified health information for the purpose of pharmacovigilance, safety monitoring, and regulatory reporting. I understand that identifiable information may be retained as required by applicable safety reporting regulations and that personal data may be processed and stored in accordance with organizational privacy policies.

I acknowledge that I may withdraw this authorization at any time by submitting a written request to the reporting facility; however, withdrawal will not affect processing of data already lawfully collected or disclosed for safety reporting. Where required by law, certain adverse event information may be reported to regulatory authorities or manufacturers without further consent to comply with legal obligations.

Documentation and Attachments

Documents attached (check applicable):   Lab reports    Imaging    Medical records    Photographs

Signature and Certification

By signing below I certify that I am authorized to report this information and that the information provided is accurate to the best of my knowledge. I understand the data will be used for pharmacovigilance purposes and may be shared with manufacturers and regulatory authorities as required.

Patient / Authorized Representative Name:

By:

Date:

Relationship to Patient (if not patient):    I am the patient    I am the parent/guardian or legal representative

If signed by a representative, provide legal authority to sign (e.g., power of attorney, guardian order) and attach supporting documentation.

Enter text✕

What the Healthcare Pharmacovigilance Activities Form Is

The Healthcare Pharmacovigilance Activities Form is a standardized record used to document safety monitoring tasks tied to medicines or biologics, including adverse event reports, signal assessments, and follow-up actions. It captures reporter identity, patient and product details, a clear narrative of the event, clinical assessments, outcome and remedial steps, and routing metadata for regulatory submission and company case management. In U.S. settings this form must be handled in ways consistent with HIPAA for protected health information and with electronic-signature laws (ESIGN/UETA) when submitted or signed electronically.

Why a Professional Pharmacovigilance Form Matters

A complete, well-structured pharmacovigilance form speeds regulatory reporting, preserves forensic audit trails, and reduces queries from regulators. It protects patient privacy, supports safety signal detection, and documents company compliance with applicable U.S. reporting obligations and internal standard operating procedures.

Why a Professional Pharmacovigilance Form Matters

Who Typically Completes and Signs This Form

The Healthcare Pharmacovigilance Activities Form is used across regulated safety workflows where accurate, auditable adverse-event documentation is required.

  • Pharmacovigilance and Drug Safety Teams — Central case management and regulatory reporting; compiles clinical and product information for submission.
  • Healthcare Providers and Hospitals — Point-of-care reporters who supply clinical narrative, diagnosis, and relevant lab or imaging details.
  • Regulatory Affairs and CROs — Review, validate causality, and submit expedited or periodic reports to regulators as required.

Teams completing and signing the form must understand their regulatory role, applicable privacy rules, and internal escalation timelines.

Primary Roles Responsible for the Form

Pharmacovigilance Manager

Oversees case intake, validation, classification, and regulatory submission. Ensures completeness of clinical data and that follow-up queries are issued and tracked until closure; coordinates cross-functional review when necessary.

Reporting Clinician

Provides the original event narrative, clinical findings, and treatment/outcome details. The clinician must confirm patient identifiers and relevant medical history and be available for follow-up clarification when requested by safety staff.

Core Sections to Include on a Professional Form

A complete Healthcare Pharmacovigilance Activities Form organizes information into discrete, consistently labeled sections to support analysis, regulatory submission, and auditability.

Reporter and Contact

Name, affiliation, contact method, and reporter type (healthcare professional, consumer, manufacturer); include consent to release protected health information when required by HIPAA.

Patient Identifiers

Non-identifying demographic fields plus a secure link to the medical record or unique case ID; follow internal privacy rules to avoid unnecessary PHI exposure.

Suspect Product Information

Product name, lot/batch, dosage, route, start/stop dates, and concomitant medications or devices relevant to causality assessment.

Event Narrative

Clear chronology of onset, signs, symptoms, diagnostic findings, and clinical interventions; include severity grading and hospitalization status if applicable.

Assessment and Outcome

Clinical assessment of causality, seriousness criteria, outcome (recovered, ongoing, fatal), and any corrective actions taken or recommended.

Regulatory Routing and Audit Data

Internal triage decision, expedited reporting indicators, submission timestamps, and an audit trail covering user, IP, and signature metadata for compliance.

Stepwise Process to Complete and Submit the Form

Use this sequence to reduce errors and meet internal and regulatory timelines.

  • 01
    Collect Case Data: Assemble reporter, patient, product, and clinical information.
  • 02
    Verify Identifiers: Confirm reporter identity and patient linkage per privacy rules.
  • 03
    Assess Reportability: Determine seriousness and expedited reporting requirements.
  • 04
    Sign and Route: Obtain required signatures then route to case processing and regulatory submission.

Typical Digital Workflow Settings for eSubmission

Configure the electronic workflow so data validation, signer authentication, and routing match your internal SOPs and regulatory needs.

Field Configuration
Authentication Method Email link, SMS code, or enterprise SSO depending on risk.
Field Validation Require date format, numeric ranges, and mandatory event fields.
Conditional Fields Show follow-up questions only when seriousness criteria are checked.
Retention Setting Apply secure archival policy aligned to HIPAA and company retention schedules.

How Electronic Submission Typically Proceeds

Digital submission tracks each action and produces an audit trail that supports regulatory defense and internal quality control.

  • Upload or Create: Start with a template or upload a completed PDF form.
  • Place Fields: Add signer, date, and conditional fields where required.
  • Authenticate Signer: Use SMS, email link, or stronger methods for critical reports.
  • Capture Audit: System stores IP, timestamp, and action history for each event.

Technical Requirements and Integrations to Consider

Choose tools that support secure file formats, robust authentication, and integration with safety databases and EHRs.

  • File Formats: PDF and DOCX supported for archival and exchange.
  • Enterprise Integrations: Connectors to Salesforce, NetSuite, and Google Workspace.
  • Signer Authentication: Email, SMS, SSO, and optional KBA for higher assurance.

Common Reporting Windows and Timelines

Pharmacovigilance workflows use internal and regulatory timelines; align your form completion with both to avoid late reporting.

Immediate Internal Notification:

Notify safety team within 24–48 hours of learning about a serious event.

Expedited Regulatory Reporting:

Prepare for regulatory expedited windows (commonly 7–15 days depending on severity and jurisdiction).

Follow-up Reports:

Submit additional information as it becomes available, typically within 30 days of initial report.

Periodic Safety Reports:

Adhere to scheduled periodic reports required by regulators and MAH obligations.

Internal SLA:

Define internal SLAs for triage, case entry, and sign-off to ensure timeliness.

Common Mistakes to Avoid

  • Incomplete clinical narrative that lacks chronology or diagnostic detail, delaying regulatory review.
  • Missing product identifiers such as batch or lot number, impeding traceability and recalls.
  • Inaccurate reporter contact details that prevent follow-up and extend case resolution time.
  • Using unsecured email or storage for PHI in violation of privacy and company policy.

Risks and Consequences of Incorrect or Late Submission

HIPAA Noncompliance: Civil penalties and enforcement actions may follow breaches or improper PHI handling.
Regulatory Enforcement: Late or inadequate reporting can prompt inspections and formal regulatory notices.
Data Integrity Issues: Incomplete or altered records undermine case credibility and regulatory trust.
Legal Exposure: Poor documentation increases liability in litigation and regulatory proceedings.
Operational Delays: Missing or inconsistent fields force rework and slow safety signal detection.
Reputation Impact: Publicized failures in safety reporting can harm company and product reputations.

Security and Compliance Controls to Look For

In-Transit Encryption: TLS 1.2/1.3
At-Rest Encryption: AES-256
HIPAA Support: BAA required
Audit Trail: Timestamps and user/IP logs
Regulatory Standards: 21 CFR Part 11 support
Certifications: SOC 2 Type II and ISO 27001

Real-World Use Cases and Typical Outcomes

Practical examples show how consistent form use reduces review cycles and improves regulatory clarity across organizations.

Hospital Safety Reporting

A hospital pharmacovigilance unit used the form to standardize reporting across 12 departments

  • Reduced follow-up queries by 40%
  • The standardized narrative and mandatory fields cut review time and ensured timely escalation to the manufacturer's safety desk.

Sponsor Case Intake

A pharma safety team deployed a digital intake template for investigator reports

  • Improved initial triage accuracy
  • Automated validation and routing reduced manual entry errors and accelerated regulatory filing readiness.

eSignature Vendor Pricing and Feature Comparison

Compare common vendor starting prices and basic capabilities relevant to healthcare pharmacovigilance workflows; signNow is listed first for reference.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Varies by vendor Varies by vendor Varies by vendor Varies by vendor
Bulk Send Yes Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes Varies by plan Varies by plan
Envelope Cap No cap 100 envelopes/user/year Varies by plan Varies by plan Varies by plan

Frequently Asked Questions and Troubleshooting

Answers to common questions about completing, signing, and storing Healthcare Pharmacovigilance Activities Forms.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users